The sale of an Aspire LPP care home development site in Tenterden, Kent, to Barchester Healthcare has been announced.

Aspire LPP received planning consent for the 64-bedroom care home development following a proactive planning process with the local council, resulting in a contemporary design for the care home which will meet the demands of the local area.

The consented care home will have en suite wet rooms in all bedrooms, a café, hair salon, activity room, cinema, lounge and dining rooms, a rooftop bar with summer lounge, balconies, and a screened roof garden. Enclosed and landscaped gardens will have new planting and seating areas, providing residents with multiple areas to engage with the outdoor environment. 

The home will be situated in a prominent roadside location off the A28, with easy access to the town of Tenterden, Kent. The historic town is situated on the eastern border of the High Weald Area of Outstanding Natural Beauty. 

“Aspire LPP is delighted to have delivered this Tenterden care home development site, working with Barchester Healthcare,” said Michael Lucas, founder and managing director at Aspire LPP. “This development represents one in a pipeline of care home developments which Aspire LPP is delivering to the market during 2022 and beyond. We are proud to play a significant role in providing a best-in-class new care home to the Tenterden community. Aspire LPP is again demonstrating its ability to work at a local level with the community and key local stakeholders to achieve a successful planning outcome in the care sector.”

Julian Burgess, land buyer at Barchester Healthcare, commented: “Barchester Healthcare are very pleased to be part of the successful planning application in Tenterden. We feel that we will be able to contribute hugely to the community with our proposed new care home. We are currently the largest developer/operator of new care homes in the UK and, as such, also provide many new jobs as well as much needed care for the elderly.”

Jordan Rundle, director in the Care Development and Investment team at Christie & Co, brokered the deal.